Firefly Neuroscience Ends $1 Million Securities Purchase Agreement With Investor
Firefly Neuroscience and an accredited investor mutually agreed in writing on June 25, 2026 to terminate a securities purchase agreement dated May 6, 2026. The deal would have sold up to 666,667 units at $1.50 per unit, for up to $1,000,000 in gross proceeds. The filing does not give a reason for the termination, and the company does not say whether it will seek other financing.
Key points
- Purchase agreement dated May 6, 2026 covered up to 666,667 units at $1.50 per unit
- Aggregate gross proceeds of up to $1,000,000 were contemplated
- Termination mutually agreed in writing on June 25, 2026, effective as of that date
- Filing made under Item 1.02 and signed by CEO Greg Lipschitz on June 26, 2026
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 26, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.